Hao Zeng Yalun Li Ye Wang Meijuan Huang Yan Zhang Panwen Tian Weimin Li
10.3389/fonc.2021.722843
Front Oncol
2021 Aug 13;11:722843.
alk fusion alectinib double-fusion variant lung adenocarcinoma targeted therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/34485156/
Case Reports
PMC8415000
34485156
Case Report: Identification of Two Rare Fusions, PDK1-ALK and STRN-ALK, That Coexist in a Lung Adenocarcinoma Patient and the Response to Alectinib
2021